- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Pan-HLA antibody detects human leukocyte antigen proteins, a group of major histocompatibility complex class I and class II molecules encoded by the HLA gene cluster. HLA proteins present peptide antigens to T cells, enabling adaptive immune recognition of pathogens and abnormal self. Because HLA molecules are expressed on nearly all nucleated cells and vary widely among individuals, Pan-HLA antibody is a valuable tool for immunology, transplantation, and oncology research.
HLA proteins consist of a peptide-binding groove that accommodates short antigenic fragments, a transmembrane region, and a cytoplasmic tail. Class I molecules such as HLA-A, HLA-B, and HLA-C present peptides to CD8+ T cells, while class II molecules like HLA-DR, HLA-DP, and HLA-DQ present peptides to CD4+ T cells. This antigen presentation system underpins immune surveillance, shaping responses to infection, tumors, and autoimmunity.
The Pan-HLA antibody clone HLA-Pan/2967R provides broad and consistent recognition across multiple HLA alleles. Recombinant production ensures reproducibility, minimizing variability in assays where precise detection of HLA is critical. Clone HLA-Pan/2967R has been cited in peer-reviewed studies exploring immune regulation, tumor immunology, and transplantation biology. Its versatility supports applications in flow cytometry, immunohistochemistry, and functional assays.
Research using clone HLA-Pan/2967R has clarified how HLA expression levels correlate with immune recognition and therapeutic response. In oncology, tumors frequently downregulate HLA molecules to evade cytotoxic T-cell responses, and this antibody enables quantification of such immune escape mechanisms. In transplantation research, HLA detection provides insight into donor-recipient compatibility and rejection risk. In autoimmune studies, Pan-HLA detection assists in characterizing antigen presentation pathways that contribute to aberrant T-cell activation.
NSJ Bioreagents supplies this Pan-HLA antibody to support immunology, cancer biology, and transplant research. Alternate names include HLA class I and class II antibody, major histocompatibility complex antibody, MHC antigen antibody, human leukocyte antigen system antibody, and HLA family protein antibody.
HLA-Pan/2967R reacts with a common epitope of human major histocompatibility (MHC) class II antigens, HLA-DP, -DQ and -DR.
Optimal dilution of the Pan-HLA antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
The non-T, non-B human acute lymphoblastic leukemia REH6 cell line was used as the immunogen for the Pan-HLA antibody.
Store the Pan-HLA antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.